[HTML][HTML] Targeting STAT3 in cancer immunotherapy

S Zou, Q Tong, B Liu, W Huang, Y Tian, X Fu - Molecular cancer, 2020 - Springer
As a point of convergence for numerous oncogenic signaling pathways, signal transducer
and activator of transcription 3 (STAT3) is central in regulating the anti-tumor immune …

[HTML][HTML] A comprehensive overview of globally approved JAK inhibitors

AM Shawky, FA Almalki, AN Abdalla, AH Abdelazeem… - Pharmaceutics, 2022 - mdpi.com
Janus kinase (JAK) is a family of cytoplasmic non-receptor tyrosine kinases that includes
four members, namely JAK1, JAK2, JAK3, and TYK2. The JAKs transduce cytokine signaling …

Targeting the IL-6/JAK/STAT3 signalling axis in cancer

DE Johnson, RA O'Keefe, JR Grandis - Nature reviews Clinical …, 2018 - nature.com
Abstract The IL-6/JAK/STAT3 pathway is aberrantly hyperactivated in many types of cancer,
and such hyperactivation is generally associated with a poor clinical prognosis. In the …

Myeloid immunosuppression and immune checkpoints in the tumor microenvironment

K Nakamura, MJ Smyth - Cellular & molecular immunology, 2020 - nature.com
Tumor-promoting inflammation and the avoidance of immune destruction are hallmarks of
cancer. While innate immune cells, such as neutrophils, monocytes, and macrophages, are …

Therapeutically exploiting STAT3 activity in cancer—using tissue repair as a road map

J Huynh, A Chand, D Gough, M Ernst - Nature Reviews Cancer, 2019 - nature.com
The tightly orchestrated temporal and spatial control of signal transducer and activator of
transcription 3 (STAT3) activity in epithelial, immune and stromal cells is critical for wound …

[HTML][HTML] The multifaced role of STAT3 in cancer and its implication for anticancer therapy

M Tolomeo, A Cascio - International journal of molecular sciences, 2021 - mdpi.com
Signal transducer and activator of transcription (STAT) 3 is one of the most complex
regulators of transcription. Constitutive activation of STAT3 has been reported in many types …

[HTML][HTML] IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion

LC Chan, CW Li, W Xia, JM Hsu… - The Journal of …, 2019 - Am Soc Clin Investig
Glycosylation of immune receptors and ligands, such as T cell receptor and coinhibitory
molecules, regulates immune signaling activation and immune surveillance. However, how …

Signaling pathways in inflammation and anti-inflammatory therapies

YT Yeung, F Aziz, A Guerrero-Castilla… - Current …, 2018 - ingentaconnect.com
During the past decade, an abundance of new evidence highlighted the importance of
inflammation in the development of chronic pathologies such as neurodegeneration, cancer …

Advances in covalent kinase inhibitors

A Abdeldayem, YS Raouf, SN Constantinescu… - Chemical Society …, 2020 - pubs.rsc.org
Over the past decade, covalent kinase inhibitors (CKI) have seen a resurgence in drug
discovery. Covalency affords a unique set of advantages as well as challenges relative to …

[HTML][HTML] The JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance

SY Park, CJ Lee, JH Choi, JH Kim, JW Kim… - Journal of Experimental …, 2019 - Springer
Background Radiotherapy (RT) is a highly effective multimodal nonsurgical treatment that is
essential for patients with advanced colorectal cancer (CRC). Nevertheless, cell …